Evidence map›Paper›PMID 37572177›Full record

ArticlePurinergic signalling2024

Tumoral P2Y

Kevin Muñoz Forti, Lucas T Woods, Kimberly J Jasmer, Jean M Camden, Gary A Weisman

Open access · greenAbstract read
In one paragraph

Article in Purinergic signalling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kevin Muñoz FortiDepartment of Biochemistry, University of Missouri, Columbia, MO, USA.
Lucas T WoodsDepartment of Biochemistry, University of Missouri, Columbia, MO, USA.
Kimberly J JasmerDepartment of Biochemistry, University of Missouri, Columbia, MO, USA.
Jean M CamdenDepartment of Biochemistry, University of Missouri, Columbia, MO, USA.
Gary A WeismanDepartment of Biochemistry, University of Missouri, Columbia, MO, USA. weismang@missouri.edu.
University of Missouri · US

Funding

VIP RECEPTORS AND SUBMANDIBULAR GLAND FUNCTIONR01DE007389 · NIDCR · UNIVERSITY OF MISSOURI-COLUMBIA · PI WEISMAN, GARY ANDREW · 1988 to 2020
$7.6M
The P2X7 receptor for ATP as a therapeutic target in the prevention of radiation-induced salivary gland dysfunctionR01DE032032 · NIDCR · UNIVERSITY OF MISSOURI-COLUMBIA · PI GARY Andrew WEISMAN · 2023 to 2026
$2.1M
NIDCR NIH HHS R01 DE007389NIDCR NIH HHS R01-DE007389NIDCR NIH HHS R01 DE032032The Ryan Foundation The Wayne L. Ryan FellowshipUniversity of Missouri Life Sciences FellowshipUniversity of Missouri School of Medicine TRIUMPH grant
6 · The paper itself

Abstract

Head and neck squamous cell carcinomas (HNSCCs) are a heterogenous group of tumors and among the top 10 most common cancers and they arise from the epithelial tissues of the mucosal surfaces of the oral cavity, oropharynx, and larynx. Aberrant purinergic signaling has been associated with various cancer types. Here, we studied the role of the P2Y

Indexed as

Mouth NeoplasmsReceptors, Purinergic P2Y2AnimalsCell Line, TumorDisease Models, AnimalHumansMiceMice, Inbred C57BLMice, KnockoutSquamous Cell Carcinoma of Head and NeckReceptors, Purinergic P2Y2ATPHNSCCImmune responseOSCCP2Y2RUTP

Identifiers

PMID37572177
PMCPMC11303632
OpenAlexW4385782780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.